- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Zealand Pharma A/S (ZELA)
895.50
+42.50(+4.98%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
844.00
905.50
52 wk Range
274.40
972.00
ZELA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Zealand Pharma A/S stock price live, this page displays CSE ZELA stock exchange data. View the ZELA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Zealand Pharma A/S real time stock price chart below.
What Is the Zealand Pharma A/S Stock Price Today?
The Zealand Pharma A/S stock price today is 895.50.
What Is the Stock Symbol for Zealand Pharma A/S?
The stock symbol for Zealand Pharma A/S is "ZELA."
What Stock Exchange Does Zealand Pharma A/S Trade On?
Zealand Pharma A/S is listed and trades on the Copenhagen stock exchange.
Is Zealand Pharma A/S a Good Stock to Buy?
Determining whether Zealand Pharma A/S—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ZELA quote. (ISIN: DK0060257814)
What Is the Zealand Pharma A/S Stock Price Today?
The Zealand Pharma A/S stock price today is 895.50.
What Is the Stock Symbol for Zealand Pharma A/S?
The stock symbol for Zealand Pharma A/S is "ZELA."
What Stock Exchange Does Zealand Pharma A/S Trade On?
Zealand Pharma A/S is listed and trades on the Copenhagen stock exchange.
Is Zealand Pharma A/S a Good Stock to Buy?
Determining whether Zealand Pharma A/S—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ZELA quote. (ISIN: DK0060257814)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
844.00905.50
52 wk Range
274.40972.00
UnlockZELA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Buy
Price Target
1,022.29
Upside
+14.16%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Zealand Pharma A/S Company Profile
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company offers Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon that is in Phase III clinical trials for treating congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark.
Compare ZELA to Peers and Sector
Metrics to compare | ZELA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipZELAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −89.2x | −2.7x | −0.6x | |
PEG Ratio | −2.17 | −0.01 | 0.00 | |
Price/Book | 6.8x | 4.0x | 2.6x | |
Price / LTM Sales | 172.6x | 11.2x | 3.1x | |
Upside (Analyst Target) | 26.6% | 47.6% | 57.8% | |
Fair Value Upside | Unlock | 10.6% | 7.6% | Unlock |
People Also Watch
FAQ
What Is the Zealand Pharma (ZELA) Stock Price Today?
The Zealand Pharma stock price today is 895.50
What Stock Exchange Does Zealand Pharma Trade On?
Zealand Pharma is listed and trades on the Copenhagen stock exchange.
What Is the Stock Symbol for Zealand Pharma?
The stock symbol for Zealand Pharma is "ZELA."
What Is the Zealand Pharma Market Cap?
As of today, Zealand Pharma market cap is 63.56B.
What is Zealand Pharma Earnings Per Share?
The Zealand Pharma EPS is -11.82.
What Is the Next Zealand Pharma Earnings Date?
Zealand Pharma will release its next earnings report on 06 Nov 2024.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.